SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulfamethoxazole And Trimethoprim Double Strength, and when can generic versions of Sulfamethoxazole And Trimethoprim Double Strength launch?
Sulfamethoxazole And Trimethoprim Double Strength is a drug marketed by Fosun Pharma, Heritage Pharma Avet, Martec Usa Llc, Mutual Pharm, Roxane, and Watson Labs. and is included in six NDAs.
The generic ingredient in SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfamethoxazole And Trimethoprim Double Strength
A generic version of SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH?
- What are the global sales for SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH?
- What is Average Wholesale Price for SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH?
Summary for SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 27 |
| Clinical Trials: | 151 |
| Patent Applications: | 2,533 |
| DailyMed Link: | SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH at DailyMed |
Recent Clinical Trials for SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cairo University | Phase 4 |
| Johns Hopkins University | Early Phase 1 |
| Chang Gung Memorial Hospital | Phase 1/Phase 2 |
See all SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH clinical trials
